Human papillomavirus (HPV) cotesting in conjunction with a PAP smear every 5 years is the preferred method for cervical cancer screening of women age 30-64 by The American Cancer Society (ACS), the American Society for Colposcopy and Cervical Pathology (ASCCP), and the American Society for Clinical Pathology (ASCP). Guidelines also recommend HPV testing for follow-up evaluation in women age 20-30 with ASC-US cytology and HPV genotyping for 16/18 is recomended when HPV is positive and cytology negative.
Aptima® HPV: HPV Types 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66 and 68.
1.0 mL ThinPrep® PAP solution
1.0 mL SurePath™ Test Pack solution
HPV detected/not detected
Used to screen women with ASC-US cervical cytology results to determine the need for referral to colposcopy.
To be used adjunctively with cervical cytology to screen women 30 years of age and older to determine the presence or absence of high risk HPV types.
Aptima and ThinPrep are registered trademarks of Hologic
SurePath is a trademark of Becton, Dickinson and Company.